LLY

764.29

+2.02%↑

JNJ

176.51

-0.67%↓

ABBV

216.25

-0.31%↓

UNH

340.54

-2.38%↓

AZN

77.78

-0.23%↓

LLY

764.29

+2.02%↑

JNJ

176.51

-0.67%↓

ABBV

216.25

-0.31%↓

UNH

340.54

-2.38%↓

AZN

77.78

-0.23%↓

LLY

764.29

+2.02%↑

JNJ

176.51

-0.67%↓

ABBV

216.25

-0.31%↓

UNH

340.54

-2.38%↓

AZN

77.78

-0.23%↓

LLY

764.29

+2.02%↑

JNJ

176.51

-0.67%↓

ABBV

216.25

-0.31%↓

UNH

340.54

-2.38%↓

AZN

77.78

-0.23%↓

LLY

764.29

+2.02%↑

JNJ

176.51

-0.67%↓

ABBV

216.25

-0.31%↓

UNH

340.54

-2.38%↓

AZN

77.78

-0.23%↓

Search

Microbot Medical Inc

Отворен

3.43 -1.15

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.4

Максимум

3.55

Ключови измерители

By Trading Economics

Приходи

-899K

-3.5M

Марж на печалбата

-4,038.095

Служители

20

EBITDA

-84K

-3.5M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+196.3% upside

Дивиденти

By Dow Jones

Следващи печалби

11.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

90M

218M

Предишно отваряне

4.58

Предишно затваряне

3.43

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.09.2025 г., 22:39 ч. UTC

Придобивния, сливания и поглъщания

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15.09.2025 г., 16:43 ч. UTC

Значими двигатели на пазара

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15.09.2025 г., 16:42 ч. UTC

Значими двигатели на пазара

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15.09.2025 г., 16:35 ч. UTC

Значими двигатели на пазара

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15.09.2025 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15.09.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15.09.2025 г., 22:48 ч. UTC

Пазарно говорене

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15.09.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

CSL Expects Commercial Launch in 2029

15.09.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15.09.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15.09.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

CSL to Have Right to Exercise Option Based on Phase 3 Data

15.09.2025 г., 22:10 ч. UTC

Придобивния, сливания и поглъщания

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15.09.2025 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15.09.2025 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15.09.2025 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15.09.2025 г., 21:14 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.09.2025 г., 19:29 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15.09.2025 г., 19:14 ч. UTC

Пазарно говорене

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15.09.2025 г., 18:16 ч. UTC

Пазарно говорене

Gold Powers to New High -- Market Talk

15.09.2025 г., 18:05 ч. UTC

Пазарно говорене

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15.09.2025 г., 17:50 ч. UTC

Придобивния, сливания и поглъщания

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15.09.2025 г., 17:10 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2025 г., 17:10 ч. UTC

Пазарно говорене

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15.09.2025 г., 16:52 ч. UTC

Пазарно говорене

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15.09.2025 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.09.2025 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

196.3% нагоре

12-месечна прогноза

Среден 12 USD  196.3%

Висок 12 USD

Нисък 12 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

Краткосрочен план

Neutral Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat